Sunovion Pharmaceuticals

Sunovion Pharmaceuticals Employee Directory

Pharmaceutical ManufacturingMassachusetts, United States501-1000 Employees

We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric  conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala®  Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. 

Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and  connect on Twitter and Facebook @Sunovion.

LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd.
APTIOM is used under license from BIAL.
KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc.
LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc.

© 2023 Sunovion Pharmaceuticals Inc.

To view our community guidelines, see here: bit.ly/3CozDLX

Sunovion Pharmaceuticals Global Highlights

Location
Employees

North America
2.6K

Minus sign iconPlus sign icon
  • United States Of America
    2.5K
  • Canada
    55
  • Mexico
    22

Europe
46

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    32
  • Romania
    4
  • Netherlands
    2
  • France
    2
  • Norway
    2
  • Denmark
    1
  • Sweden
    1
  • Spain
    1
  • Switzerland
    1

Asia
22

Minus sign iconPlus sign icon
  • India
    12
  • Japan
    4
  • Singapore
    2
  • China
    1
  • Iran
    1
  • Sri Lanka
    1
  • Nepal
    1

South America
4

Minus sign iconPlus sign icon
  • Brazil
    2
  • Peru
    1
  • Venezuela
    1

Africa
3

Minus sign iconPlus sign icon
  • Algeria
    1
  • Togo
    1
  • Benin
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

Sunovion Pharmaceuticals's Leadership

Contact profiles from Sunovion Pharmaceuticals

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    M. O.
    Senior Event Partner
    United StatesMassachusetts
    May 01, 2024
  • Stylized image of a person
    Y. S.
    Evp, Chief Corporate Strategy Officer
    United StatesMassachusetts
    Jan 17, 2024
  • Stylized image of a person
    A. L.
    Chief Medical Officer
    United StatesNew York
    May 07, 2024
  • Stylized image of a person
    A. L.
    President And Chief Executive Officer
    United StatesNew York
    Feb 16, 2024
  • Stylized image of a person
    D. K.
    Human Resources Staffing Partner
    United StatesMassachusetts
    Nov 17, 2023
  • Stylized image of a person
    D. M.
    Executive Assistant To The Executive Vice President & Chief Administrative Officer
    United StatesMassachusetts
    May 07, 2024
  • Stylized image of a person
    M. O.
    Sr. Project Coodinator To The Cso
    United StatesMassachusetts
    May 07, 2024
  • Stylized image of a person
    S. W.
    Assistant To Executive Vice President & Cmo
    May 01, 2024
  • Stylized image of a person
    J. C.
    Principal And Founder Clinconsults Llc
    United StatesNew Jersey
    May 05, 2024
  • Stylized image of a person
    F. B.
    Owner
    UNITED STATES
    Mar 04, 2024

Frequently Asked Questions

What is Sunovion Pharmaceuticals known for?

Minus sign iconPlus sign icon
Sunovion Pharmaceuticals was founded in 2010 operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 84 Waterford Dr Marlborough, MA 01752 US; you can contact the main corporate office by phone at +1-201-592-5044. Explore Sunovion Pharmaceuticals's company overview page for more information.

What is Sunovion Pharmaceuticals's most common email format?

Minus sign iconPlus sign icon
Sunovion Pharmaceuticals employees' email format typically follows the pattern of first.middle@sunovion.com. Trying to find reliable and up-to-date employee contact data? Find more Sunovion Pharmaceuticals email formats with LeadIQ.

How many employees does Sunovion Pharmaceuticals have currently?

Minus sign iconPlus sign icon
Sunovion Pharmaceuticals has approximately 1.1K employees as of April 2024. These team members are located across 6 continents, including North AmericaEuropeAsia.

Who are Sunovion Pharmaceuticals's key employees and leadership?

Minus sign iconPlus sign icon

As of April 2024, Sunovion Pharmaceuticals's key employees include:

  • Chief Medical Officer: A. L.
  • Chief Scientific Officer: J. M.
  • Chief Power Engineer: R. K.
  • Vice President Corporate Operations: T. H.
  • Vice President Deputy General Counsel And Chief Ip Counsel: D. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

© LeadIQ, Inc. All rights reserved.